Page 884 - Motor Disorders Third Edition
P. 884

866 / chapter 57                                                 family of CLN4B was characterized by seizures, dementia,
imbalance, would not explain white matter destruction;           and myoclonus, and several individuals had parkinsonism
however, mitochondrial abnormalities, so noted in the            prior to known molecular genetic localization to DNAJC5
liver of one patient with WD (46), suggested a contribu-         (50). The same investigators (51) identified a heterozygous
tion of mitochondrial injury to other organs, including          mutation in the DNAJC5 gene in a Czech family with auto-
the brain. Mutation of the WD protein, that results in           somal dominant ACLN manifesting progressive confusion
accumulation of intracellular copper and lead to oxidative       and dementia as well as frequent medically refractory gen-
attacks and damage within target tissues, is suggested by        eralized seizures. Brain MRI in the proband, age 38 years,
the correlation between severity of the neuropathological        showed prominence of cortical sulci and cerebellar folds,
findings and cerebral copper content (47).                       and mild lateral ventricular enlargement consistent with
                                                                 diffuse cerebral and cerebellar atrophy. Concurrent neuro-
ADULT NEURONAL CEROID                                            psychiatric testing showed a full-scale intelligence quotient
LIPOFUSCINOSIS                                                   (IQ) of 73 with ensuing ataxia and myoclonus. Frontal lobe
                                                                 brain biopsy showed numerous neurons containing homog-
This disorder belongs to the neuronal ceroid-lipofuscinoses      enous eosinophilic material that stained intensely with the
(NCL) group of inherited neurodegenerative lysosomal-            periodic acid-Schiff reaction and was found to be auto-
storage disorders categorized by patterns of intracellu-         fluorescent with multiple neurons distended by granular
lar accumulation of autofluorescent lipopigment storage          osmiophilic deposits by ultrastructural examination. While
material, age at onset, and order of appearance of common        challenging and often requiring invasive brain biopsy, avail-
clinical features from infancy to adulthood, including pro-      able mutation screening for CLN4A and B should now be
gressive dementia, seizures, and visual failure (48), with       considered as initial diagnostic steps in patients with sus-
each phenotype assigned a unique ceroid lipofuscinosis           pected Kufs disease.
(CLN) gene symbol. Kufs disease or adult ceroid lipofus-
sinase (ACLN) presents in patients ranging from teenagers        HUNTINGTON DISEASE
to persons greater than age 50 years, has a typical age at
onset of 30 years, and differs from other forms of NCL in        This phenotypically heterogeneous autosomal dominant
preservation of vision due to lack of retinal involvement.       disorder presents in previously healthy persons age five to
Until recently, brain biopsy was required to confirm the         eight years, but mainly in the fourth to fifth decades of life,
diagnosis of ACLN because, unlike other forms of NCL             with chorea, dystonia, incoordination, cognitive decline,
in which electron microscopy (EM) can be performed on            and behavioral disturbances. The cause of the disorder is
heparinized whole blood lymphocytes and tissue biopsy of         abnormally expanded trinucleotide CAG repeats in the
skin, conjunctiva, or other tissue, the characteristic lipopig-  HTT gene located on chromosome 4p16.3 encoding hun-
ment in Kufs disease is largely confined to neurons. The         tingtin. The detection of an expansion of 36 or more CAG
two clinical subtypes of Kufs disease, classically designated    repeats in HTT in the setting of a positive family pedigree,
type A and B for the differing clinical presentation, have       and characteristic clinical findings, makes the diagnosis
since been categorized by their respective CLN designa-          essentially certain. The length of CAG repeats correlates
tions, CLN4A and CLN4B, allowing further separation by           with an earlier age of onset, a cognitive behavioral presen-
mode of inheritance and causative genetic mutations, with        tation, and an accelerated disease progression. Subcortical
minor phenotypic overlap. Kufs type A disease (CLN4A),           cognitive dysfunction in HD, which typically spares long-
which displays autosomal recessive inheritance, is caused        term memory but impairs executive functions such as orga-
by homozygous or compound heterozygous mutation at the           nization, planning, checking, or adaptation of alternatives,
15q23 locus of the CLN6 gene encoding ceroid-lipofuscino-        and delays the acquisition of new motor skills (52), wors-
sis neuronal protein 6, presents generally with progressive      ens over time with speech deteriorating faster than com-
myoclonic epilepsy, whereas CLN4B, manifesting autoso-           prehension. Unlike cognitive disturbances, psychiatric and
mal dominant inheritance, is due to heterozygous mutation        behavioral involvement seen in 98% of patients, including
at the 20q13.33 locus of the DNAJC5 gene encoding cyste-         depression, apathy, aggression and disinhibition, do not
ine-string protein alpha, presenting instead with dementia       proceed in a stepwise progression along with worsening
and a variety of motor-system signs. Accordingly, among          disease severity.
four families with Kufs disease for whom there was good
evidence of an autosomal recessive inheritance, three were          Patients with juvenile HD (JHD), defined as onset before
affected by Kufs type A disease, presenting with tonic-clonic    age 20 years (53), can have an insidious onset with nonspe-
seizures or action myoclonus, followed by ataxia, cogni-         cific psychiatric and cognitive difficulties. Among a cohort
tive decline, or dementia (49). A four-generation Alabama        of French JDH patients (54), the commonest signs at onset
   879   880   881   882   883   884   885   886   887   888   889